Income Statement Kintor Pharmaceutical Limited OTC Markets

Stocks

KNTPF

KYG5273B1077

Biotechnology & Medical Research

Market Closed - OTC Markets 16:30:02 16/09/2026 +03			5-day change	1st Jan Change
0.2415 ^USD	+0.62%		-.--%	+11.81%

09-21	Kintor Pharmaceutical Limited Announces CFO Changes, Effective September 21, 2026	CI
09-21	Kintor Pharmaceutical Limited Announces Resignation of Ming Ming Cheung as Joint Company Secretary with Effect from September 21, 2026	CI

9b385b2.hkX8b8UO8DTTKTt3wKmTJpZJXwkpvn4IQCLIOvSYG-Q.5Q2UIpF3hUOBH3wH9p31aO88b2Bs7gY-IheBecDBUK_oL6oZtGCqWpYQUA

Published financial data: KINTOR PHARMACEUTICAL LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Revenues	34.23M	-	-	5M	32.68M
Other Revenues, Total	-	-	-	-	-
Total Revenues	34.23M	-	-	5M	32.68M
Cost of Goods Sold, Total	-	-	42.23M	3.52M	24.64M
Gross Profit	34.23M	-	-42.23M	1.48M	8.04M
Selling General & Admin Expenses, Total	118M	153M	96.03M	88M	97.88M
Provision for Bad Debts	-	-	-	1.21M	-900K
R&D Expenses	768M	828M	939M	71.49M	85.5M
Other Operating Expenses	-16.96M	-11.42M	-7.49M	-17.43M	-1.89M
Other Operating Expenses, Total	869M	969M	1.03B	143M	181M
Operating Income	-835M	-969M	-1.07B	-142M	-173M
Interest Expense, Total	-2.49M	-8.19M	-9.69M	-9.28M	-3.94M
Interest And Investment Income	12.05M	6.88M	13.08M	4.21M	108K
Net Interest Expenses	9.56M	-1.3M	3.39M	-5.07M	-3.84M
Income (Loss) On Equity Invest.	-	-568K	52K	-1.43M	766K
Currency Exchange Gains (Loss)	-17.62M	16.33M	-3.13M	3.73M	-39K
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	-843M	-955M	-1.07B	-145M	-176M
Gain (Loss) On Sale Of Investments	777K	2M	491K	1K	-
Gain (Loss) On Sale Of Assets	-106K	-620K	10K	2.52M	-60K
Asset Writedown	-	-	-	-13.25M	-27.24M
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-842M	-953M	-1.07B	-155M	-203M
Income Tax Expense	-	1.08M	-8.04M	18K	-2.85M
Earnings From Continuing Operations	-842M	-954M	-1.06B	-155M	-200M
Net Income to Company	-842M	-954M	-1.06B	-155M	-200M
Net Income - (IS)	-842M	-954M	-1.06B	-155M	-200M
Net Income to Common Incl Extra Items	-842M	-954M	-1.06B	-155M	-200M
Net Income to Common Excl. Extra Items	-842M	-954M	-1.06B	-155M	-200M
Per Share Items
Net EPS - Basic	-2.36	-2.53	-2.47	-0.36	-0.44
Basic EPS - Continuing Operations	-2.36	-2.53	-2.47	-0.36	-0.44
Basic Weighted Average Shares Outstanding	356M	377M	429M	431M	450M
Net EPS - Diluted	-2.36	-2.53	-2.47	-0.36	-0.44
Diluted EPS - Continuing Operations	-2.36	-2.53	-2.47	-0.36	-0.44
Diluted Weighted Average Shares Outstanding	356M	377M	429M	431M	450M
Normalized Basic EPS	-1.48	-1.58	-1.56	-0.21	-0.24
Normalized Diluted EPS	-1.48	-1.58	-1.56	-0.21	-0.24
Supplemental Items
EBITDA	-828M	-956M	-1.06B	-129M	-141M
EBITA	-835M	-969M	-1.07B	-142M	-155M
EBIT	-835M	-969M	-1.07B	-142M	-173M
EBITDAR	-827M	-955M	-1.06B	-128M	-140M
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	-	-0.11	0.75	-0.01	1.41
Total Current Taxes	-	1.08M	-266K	18K	1.51M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-7.78M	-	-4.36M
Normalized Net Income	-527M	-597M	-668M	-90.34M	-110M
Interest Capitalized	4.4M	2.37M	2.7M	-	-
Interest on Long-Term Debt	4.57M	2.82M	3.03M	162K	52K
Supplemental Operating Expense Items
Marketing Expenses	14.7M	20.33M	6.98M	26.56M	-
Selling and Marketing Expenses	14.7M	20.33M	6.98M	26.56M	41.17M
General and Administrative Expenses	102M	131M	88.36M	60.7M	56.72M
Research And Development Expense From Footnotes	768M	828M	939M	78.14M	87.39M
Net Rental Expense, Total	1.36M	1.22M	682K	733K	524K
Imputed Operating Lease Interest Expense	395K	461K	250K	281K	151K
Imputed Operating Lease Depreciation	970K	756K	432K	452K	373K
Maintenance & Repair Expenses, Total	-	-	-	-	-
Stock-Based Comp., R&D Exp. (Total)	19.93M	57.23M	19.77M	-11.28M	-1.38M
Stock-Based Comp., S&M Exp. (Total)	-	-	-	-	-30K
Stock-Based Comp., G&A Exp. (Total)	11.95M	29.79M	10.66M	2.02M	1.73M
Stock-Based Comp., Other (Total)	5.47M	8.62M	-	-	-
Total Stock-Based Compensation	37.35M	95.64M	30.42M	-9.26M	321K

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Assets
Cash And Equivalents	930M	865M	445M	147M	32.74M
Short Term Investments	127M	11.88M	12.56M	1.27M	-
Total Cash And Short Term Investments	1.06B	877M	458M	149M	32.74M
Accounts Receivable, Total	-	-	-	-	2.8M
Other Receivables	-	-	6.48M	15.65M	1.13M
Total Receivables	-	-	6.48M	15.65M	3.93M
Inventory	351M	604M	-	2.22M	12.09M
Restricted Cash	1.66M	5.64M	425K	431K	2.03M
Other Current Assets, Total	116M	21.77M	7.6M	4.75M	4.46M
Total Current Assets	1.53B	1.51B	473M	172M	55.25M
Gross Property Plant And Equipment	283M	322M	327M	303M	249M
Accumulated Depreciation	-20.82M	-39.11M	-105M	-129M	-91.15M
Net Property Plant And Equipment	262M	282M	222M	174M	158M
Long-term Investments	-	17.94M	18M	16.57M	16.25M
Other Intangibles, Total	236M	236M	149M	149M	107M
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	44.17M	11.2M	7.9M	3.64M	4.03M
Total Assets	2.07B	2.06B	869M	515M	341M
Liabilities
Accounts Payable, Total	173M	180M	81.6M	40.96M	32.12M
Accrued Expenses, Total	25.12M	19.89M	17.32M	6.68M	3.77M
Short-term Borrowings	-	40M	20M	14.38M	65M
Current Portion of Long-Term Debt	7.4M	58.9M	93.7M	97.38M	20M
Current Portion of Leases	2.07M	4.44M	4.53M	1.25M	610K
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	12.2M	14.5M	7.58M	6.03M	6.08M
Total Current Liabilities	220M	318M	225M	167M	128M
Long-Term Debt	148M	178M	133M	20M	-
Long-Term Leases	2.76M	5.45M	2.29M	-	988K
Unearned Revenue Non Current	4.01M	19.95M	19.66M	3.32M	2.97M
Deferred Tax Liability Non Current	38.82M	38.82M	31.04M	31.04M	26.68M
Total Liabilities	413M	560M	411M	221M	158M
Common Stock, Total	273K	315K	315K	315K	351K
Additional Paid In Capital	-	4.1B	4.18B	4.21B	4.32B
Retained Earnings	-1.77B	-2.72B	-3.78B	-3.94B	-4.14B
Comprehensive Income and Other	3.42B	115M	60.73M	23.58M	4.47M
Total Common Equity	1.66B	1.5B	458M	294M	183M
Total Equity	1.66B	1.5B	458M	294M	183M
Total Liabilities And Equity	2.07B	2.06B	869M	515M	341M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	388M	447M	439M	434M	494M
ECS Total Common Shares Outstanding	388M	447M	439M	434M	494M
Book Value / Share	4.27	3.34	1.04	0.68	0.37
Tangible Book Value	1.42B	1.26B	309M	145M	75.34M
Tangible Book Value Per Share	3.66	2.81	0.7	0.33	0.15
Total Debt	160M	286M	254M	133M	86.6M
Net Debt	-897M	-591M	-204M	-15.68M	53.86M
Debt Equivalent Oper. Leases	10.92M	9.74M	5.46M	5.86M	4.19M
Equity Method Investments, Total	-	17.94M	18M	16.57M	16.25M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	346M	696M	-	-	-
Inventories - Work In Process, Total	5.08M	-	-	-	-
Inventories - Others	-	-	-	-	-
Buildings, Total	57.66M	89.23M	89.23M	89.23M	132M
Machinery, Total	46.78M	58.24M	58.7M	58.9M	70.63M
Full Time Employees	316	301	225	168	123
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Net Income	-842M	-954M	-1.06B	-155M	-200M
Depreciation & Amortization - CF	10.37M	18.24M	18.86M	17.49M	15.65M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	17.46M
Depreciation & Amortization, Total	10.37M	18.24M	18.86M	17.49M	33.11M
Amortization of Deferred Charges, Total - (CF)	143K	151K	119K	133K	103K
(Gain) Loss From Sale Of Asset	106K	620K	-10K	-2.52M	60K
(Gain) Loss on Sale of Investments - (CF)	-777K	-2M	-491K	-1K	-
Asset Writedown & Restructuring Costs	-	-	134M	13.82M	27.13M
(Income) Loss On Equity Investments - (CF)	-	568K	-52K	1.43M	-766K
Stock-Based Compensation (CF)	37.35M	95.64M	22.99M	-9.11M	321K
Provision and Write-off of Bad Debts	-	-	-	1.21M	-900K
Other Operating Activities, Total	28.13M	77.85M	594M	-15.1M	-5.79M
Change In Accounts Receivable	-86.03M	94.23M	7.62M	8.57M	-342K
Change In Inventories	-351M	-345M	-376K	-4.32M	-9.62M
Change In Accounts Payable	155M	6.76M	-107M	-49.95M	-11.3M
Change in Unearned Revenues	3.65M	15.94M	-295K	-	438K
Change In Deferred Taxes	-	-	-	-	-
Change in Other Net Operating Assets	-6.16M	30.24M	3.4M	-5.44M	-2.07M
Cash from Operations	-1.05B	-961M	-388M	-199M	-170M
Capital Expenditure	-76.24M	-27.47M	-2.72M	-1.54M	-742K
Sale of Property, Plant, and Equipment	13K	195K	210K	233K	21K
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-29.5M	-178K	-	10.29M	15.65M
Investment in Marketable and Equity Securities, Total	196M	97.84M	-848K	10M	1.08M
Other Investing Activities, Total	2.2M	-3.19M	6.64M	1.05M	-1.6M
Cash from Investing	92M	67.2M	3.27M	20.03M	14.41M
Long-Term Debt Issued, Total	20M	170M	70M	34.28M	116M
Total Debt Issued	20M	170M	70M	34.28M	116M
Long-Term Debt Repaid, Total	-113M	-53.01M	-104M	-154M	-164M
Total Debt Repaid	-113M	-53.01M	-104M	-154M	-164M
Issuance of Common Stock	952M	699M	755K	372K	88.3M
Repurchase of Common Stock	-	-	-	-	-
Other Financing Activities, Total	-2.03M	-	-	-	-
Cash from Financing	857M	816M	-33.46M	-120M	40.27M
Foreign Exchange Rate Adjustments	-36.42M	16.45M	-2.67M	2.11M	375K
Net Change in Cash	-138M	-61.86M	-420M	-297M	-115M
Supplemental Items
Cash Interest Paid	6.77M	9.96M	12.12M	9.29M	3.94M
Cash Income Tax Paid (Refund)	809K	905K	294K	18K	1.51M
Levered Free Cash Flow	-896M	-682M	-120M	-139M	-71.77M
Unlevered Free Cash Flow	-894M	-677M	-114M	-133M	-69.31M
Change In Net Working Capital	314M	157M	-508M	61.37M	9.9M
Net Debt Issued / Repaid	-92.52M	117M	-34.22M	-120M	-48.03M

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Profitability
Return on Assets	-26.62	-29.38	-45.72	-12.8	-25.2
Return on Total Capital	-29.44	-33.68	-53.62	-15.56	-30.98
Return On Equity %	-53.24	-60.59	-108.62	-41.29	-83.96
Return on Common Equity	-53.24	-60.59	-108.62	-41.29	-83.96
Margin Analysis
Gross Profit Margin %	100	-	-	29.56	24.6
SG&A Margin	344.58	-	-	1.76K	299.5
EBITDA Margin %	-2.42K	-	-	-2.57K	-431.02
EBITA Margin %	-2.44K	-	-	-2.84K	-474.53
EBIT Margin %	-2.44K	-	-	-2.84K	-527.96
Income From Continuing Operations Margin %	-2.46K	-	-	-3.11K	-612.28
Net Income Margin %	-2.46K	-	-	-3.11K	-612.28
Net Avail. For Common Margin %	-2.46K	-	-	-3.11K	-612.28
Normalized Net Income Margin	-1.54K	-	-	-1.81K	-335.92
Levered Free Cash Flow Margin	-2.62K	-	-	-2.77K	-219.61
Unlevered Free Cash Flow Margin	-2.61K	-	-	-2.66K	-212.06
Asset Turnover
Asset Turnover	0.02	-	-	0.01	0.08
Fixed Assets Turnover	0.15	-	-	0.03	0.2
Receivables Turnover (Average Receivables)	-	-	-	-	-
Inventory Turnover (Average Inventory)	-	-	-	-	3.44
Short Term Liquidity
Current Ratio	6.94	4.74	2.1	1.03	0.43
Quick Ratio	4.81	2.76	2.07	0.99	0.29
Operating Cash Flow to Current Liabilities	-4.78	-3.02	-1.72	-1.19	-1.33
Days Sales Outstanding (Average Receivables)	-	-	-	-	-
Days Outstanding Inventory (Average Inventory)	-	-	-	-	105.95
Average Days Payable Outstanding	-	-	-	-	386.35
Long Term Solvency
Total Debt/Equity	9.65	19.15	55.43	45.23	47.43
Total Debt / Total Capital	8.8	16.07	35.66	31.14	32.17
LT Debt/Equity	9.08	12.24	29.62	6.8	0.54
Long-Term Debt / Total Capital	8.28	10.27	19.06	4.68	0.37
Total Liabilities / Total Assets	19.96	27.25	47.3	42.91	46.42
EBIT / Interest Expense	-334.68	-118.37	-110.39	-15.28	-43.75
EBITDA / Interest Expense	-330.52	-116.15	-108.44	-13.4	-35.35
(EBITDA - Capex) / Interest Expense	-361.09	-119.5	-108.72	-13.56	-35.54
Total Debt / EBITDA	-0.19	-0.3	-0.24	-1.07	-0.62
Net Debt / EBITDA	1.09	0.62	0.19	0.13	-0.39
Total Debt / (EBITDA - Capex)	-0.18	-0.29	-0.24	-1.06	-0.62
Net Debt / (EBITDA - Capex)	1	0.6	0.19	0.12	-0.38
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	-	553.64
Gross Profit, 1 Yr. Growth %	-	-	-	-231.03	443.91
EBITDA, 1 Yr. Growth %	108.91	15.52	10.39	-86.06	9.51
EBITA, 1 Yr. Growth %	108.81	16.1	10.38	-84.86	9.38
EBIT, 1 Yr. Growth %	108.81	16.1	10.38	-84.86	21.7
Earnings From Cont. Operations, 1 Yr. Growth %	65.67	13.33	11.15	-85.36	28.86
Net Income, 1 Yr. Growth %	65.67	13.33	11.15	-85.36	28.86
Normalized Net Income, 1 Yr. Growth %	64.93	13.28	12.01	-84.56	21.52
Diluted EPS Before Extra, 1 Yr. Growth %	43.8	7.26	-2.45	-85.42	23.4
Accounts Receivable, 1 Yr. Growth %	-	-	-	-	-
Inventory, 1 Yr. Growth %	-	71.76	-	-	445.91
Net Property, Plant and Equip., 1 Yr. Growth %	40.51	7.69	-21.47	-21.46	-9.3
Total Assets, 1 Yr. Growth %	11.69	-0.62	-57.7	-40.74	-33.84
Tangible Book Value, 1 Yr. Growth %	9.35	-11.27	-75.45	-53.06	-48.09
Common Equity, 1 Yr. Growth %	9.76	-9.66	-69.36	-35.81	-37.91
Cash From Operations, 1 Yr. Growth %	176.03	-8.57	-59.68	-48.64	-14.74
Capital Expenditures, 1 Yr. Growth %	10.44	-63.97	-90.09	-43.52	-51.76
Levered Free Cash Flow, 1 Yr. Growth %	184.37	-23.88	-82.42	277.62	-48.66
Unlevered Free Cash Flow, 1 Yr. Growth %	185.79	-24.32	-83.19	333.29	-48.27
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-	-	-
Gross Profit, 2 Yr. CAGR %	-	-	11.07	-	166.96
EBITDA, 2 Yr. CAGR %	95.61	55.35	12.92	-63.33	-60.93
EBITA, 2 Yr. CAGR %	95.58	55.7	13.2	-61.75	-59.31
EBIT, 2 Yr. CAGR %	95.58	55.7	13.2	-61.75	-57.08
Earnings From Cont. Operations, 2 Yr. CAGR %	90.28	37.02	12.24	-59.66	-56.57
Net Income, 2 Yr. CAGR %	90.28	37.02	12.24	-59.66	-56.57
Normalized Net Income, 2 Yr. CAGR %	95.7	36.68	12.64	-61.09	-56.69
Diluted EPS Before Extra, 2 Yr. CAGR %	55.94	24.19	2.29	-62.28	-57.58
Inventory, 2 Yr. CAGR %	-	-	-	-93.94	-
Net Property, Plant and Equip., 2 Yr. CAGR %	52.5	23.01	-8.03	-21.46	-15.6
Total Assets, 2 Yr. CAGR %	93.31	5.36	-35.17	-49.93	-37.38
Tangible Book Value, 2 Yr. CAGR %	173.07	-1.5	-53.33	-66.06	-50.64
Common Equity, 2 Yr. CAGR %	111.6	-0.42	-47.39	-55.65	-36.87
Cash From Operations, 2 Yr. CAGR %	114.72	58.86	-39.28	-54.49	-33.82
Capital Expenditures, 2 Yr. CAGR %	6.48	-36.92	-81.1	-76.34	-47.8
Levered Free Cash Flow, 2 Yr. CAGR %	159.34	47.13	-63.42	-54.9	39.81
Unlevered Free Cash Flow, 2 Yr. CAGR %	160.22	47.07	-64.33	-55.68	50.34
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	266.03	-	-	-47.34	-
Gross Profit, 3 Yr. CAGR %	1.46K	-	-	-64.92	-
EBITDA, 3 Yr. CAGR %	96.96	64.11	38.63	-46.24	-47.19
EBITA, 3 Yr. CAGR %	96.73	64.37	38.83	-44.62	-45.71
EBIT, 3 Yr. CAGR %	96.73	64.37	38.83	-44.62	-43.74
Earnings From Cont. Operations, 3 Yr. CAGR %	98	60.1	27.79	-43.08	-40.59
Net Income, 3 Yr. CAGR %	98	60.1	27.79	-43.08	-40.59
Normalized Net Income, 3 Yr. CAGR %	97.49	63.09	27.91	-44.44	-43.12
Diluted EPS Before Extra, 3 Yr. CAGR %	68.17	37.65	14.59	-46.56	-44.01
Inventory, 3 Yr. CAGR %	-	-	-	-81.53	-72.84
Net Property, Plant and Equip., 3 Yr. CAGR %	124.33	35.8	5.92	-12.75	-17.6
Total Assets, 3 Yr. CAGR %	69.64	54.86	-22.28	-37.08	-45.06
Tangible Book Value, 3 Yr. CAGR %	161.71	87.73	-38.01	-53.24	-60.89
Common Equity, 3 Yr. CAGR %	87.36	59.33	-32.78	-43.78	-50.39
Cash From Operations, 3 Yr. CAGR %	109.18	61.54	0.58	-42.58	-43.9
Capital Expenditures, 3 Yr. CAGR %	143.99	-25.8	-65.96	-72.78	-70
Levered Free Cash Flow, 3 Yr. CAGR %	107.89	72.35	-27.54	-46.3	-52.78
Unlevered Free Cash Flow, 3 Yr. CAGR %	109.48	72.41	-28.62	-47.03	-53.21
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	87.98	-	-	-	-
Gross Profit, 5 Yr. CAGR %	99.32	-	442.34	-	-
EBITDA, 5 Yr. CAGR %	69.94	84.29	57.67	-9.88	-18.69
EBITA, 5 Yr. CAGR %	69.93	83.98	57.71	-8.26	-17.25
EBIT, 5 Yr. CAGR %	69.93	83.89	57.71	-8.26	-15.47
Earnings From Cont. Operations, 5 Yr. CAGR %	73.07	83.22	57.78	-7.76	-17.01
Net Income, 5 Yr. CAGR %	73.07	83.22	57.78	-7.76	-17.01
Normalized Net Income, 5 Yr. CAGR %	73.09	82.08	57.77	-8.06	-19.23
Diluted EPS Before Extra, 5 Yr. CAGR %	52.23	60.36	37.84	-17.99	-22.99
Inventory, 5 Yr. CAGR %	371.78	-	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	132.23	132.01	57.03	9.09	-3.28
Total Assets, 5 Yr. CAGR %	161.38	111	15.46	-1.42	-28.71
Tangible Book Value, 5 Yr. CAGR %	142.74	189.57	31.31	-5.28	-43.41
Common Equity, 5 Yr. CAGR %	150.29	233.38	12.73	-4.47	-34.44
Cash From Operations, 5 Yr. CAGR %	135.53	84.5	27.54	-2.68	-14.93
Capital Expenditures, 5 Yr. CAGR %	95.64	18.18	-12.3	-53.03	-59.61
Levered Free Cash Flow, 5 Yr. CAGR %	146.94	74.3	3.75	0.81	-25.6
Unlevered Free Cash Flow, 5 Yr. CAGR %	146.85	74.87	3.18	0.13	-26.02